Serge Belamant And The Blockchain Wave

Serge Belamant, and his company Net1 have embarked on a wide-ranging mission to bring their proprietary blockchain debit/credit system to the mass market. There are many of us that consider that information revolution that started in the 80s and continues to this day to be the defining movement of the 20th and 21st centuries so far. However, there is another technology that is set to be even more defining blockchain tech.

Net1, along with blockchain and crypto expert Serge Belamant are sitting on an incredibly new technology that has the potential to change everything when it comes to how and where we process transactions. Right now, this technology is poised to allow Net1 to create substantial free cash flows in the financial technology space. The stock is currently undervalued, which means that that generated cash flow has the potential to buy all of the current shares of Net1 on the market prior to the finish of the last quarter in 2023.

Their technology, which is patented, is located on a small credit or debit card that is accepted at any merchant that currently has EMV capability. EMV stands for European Master card Visa. These cards use DLP or distributed ledger technology to allow customers and merchants to utilize the blockchain when making financial transactions. Serge Belamant has decided to give this gift to the world with Net1 behind him.

One major difference between standard debit and credit systems and the new Serge Belamant led efforts is the fact that they do not need to be connected to a central server to process transactions. In truth, they do not even need a power source. The way the cards work is by being plugged into a battery POS system which can then check cards anywhere. There does not need to be a connection to a central server because they use the power of the blockchain to verify, rather than normal cards.

There are many new developments in tech, but none that are as exciting as the debit and credit blockchain tech being developed by the fine folks at Net1 alongside Serge Belamant.

To Visit More Click This Link : za.linkedin.com/pub/dir/Serge/Belamant

Ex-Sherpa Capital CEO Shervin Pishevar Caught The Trump Tweeting Illness In February

Donald Trump is the tweeting champion of the world, according to the people who follow him on Twitter. Trump likes to go around government systems and let people know what he’s thinking. But according to some financial investors, what he’s thinking doesn’t make much sense unless you think like Trump. Some people are saying the same thing about Shervin Pishevar. Shervin Pishevar is the former managing director of Menlo Ventures. Menlo Ventures is a venture capital firm that spotted Uber when it was a floundering startup. Pishevar is the guy who thought Uber was going to be big, so he invested $26 million in Uber. That investment is worth $5 billion today.

Shervin Pishevar’s investment resume is impressive. He’s been on the ground floor of startups like Warby Parker and Airbnb. He started Sherpa Capital in 2013 so he could do his own thing in the investment world, but he resigned at the end of 2017. Pishevar was silent at the beginning of 2018, but in February, Shervin Pishevar came out tweeting. Investors who know how he can spot startup winners sooner than other investors are taking Shervin’s tweet advice. Investors are leaving the stock market because of one tweet in Shervin Pishevar’s 21-hour tweetstorm reminded them the stock market is prime for another crash. A 6000-point crash, according to Pishevar.

Another Pishevar tweet claims the national debt, interest rates, and inflation are forming a perfect financial storm. And Trump’s trade agenda is fueling that storm even though Shervin didn’t name Trump in any of the 50 plus tweets he put out there on Twitter.

Some investors aren’t sure why Shervin Pishevar spent the time tweeting about issues he can’t control. But other investors know Pishevar doesn’t get on Twitter to make a name for himself. His reputation as a venture capitalist puts him in a club of venture capitalists who know how to make money even when financial markets start to go south. That’s why his tweetstorm is so interesting. Pishevar is letting the world know he’s back. He wants to show investors how to be flexible during turbulent economic times, and his tweetstorm shows them what he’s thinking.

https://mashable.com/category/shervin-pishevar/

Paul Mampilly-Digital Medicine Is Better

Paul Mampilly is one of the most vocal editors working with Banyan Hill Publications. The financial guru has been working in modern market for a very long time, and he has answers to some of the things giving consumers sleepless nights. The people who have subscribed to his newsletters from him are doing so well in their investments. Although the newsletter has not been on the market for a long time, it has managed to grow each passing day. The popularity of the financial newsletter shows that consumers love the advice they have been getting from the businessman.

Paul Mampilly and digital medication

Paul has been spending most of his time in Northern Carolina. His home area is very beautiful because it is filled with oak trees and many pines. When getting to his home, you will be impressed by the kind of beauty brought by these trees. However, when it is time to give off pollen, Paul Mampilly and his family have tough time. The pollen that comes from the trees leaves him with a constant cough and sneezing that makes him so uncomfortable. The season is always a nightmare for the American based hedge fund manager.

In one of the Banyan Hill articles, the hedge fund manager says that he has been taking medication during the season so that the cough and sneezing reduces. The finance executive, however, does not know if the medicine works or the side effects it has made him feel better. The hedge fund manager is urging technology experts to look for technology pill that will help people to understand the drugs they are taking.

Some scientists have been working towards this agenda, and they have already introduced special pill called Abilify. The drug has treated many schizophrenia patients in the country, and they can now understand whether the drug they have administered in their body is working or not. Paul Mampilly has been watching this innovation as it was introduced into the world, and he is urging members of the society to embrace it so that they can live better and even healthier lives.

Read More : www.crunchbase.com/person/paul-mampilly